BLOCK HIV/HCV
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Meeting Slides
Clinical Practice Guidelines
Considerations for Antiretroviral Use in Patients With Coinfections: Hepatitis C Virus/HIV Coinfection.
US Department of Health and Human Services (DHHS), 2017 (last updated October 2018).
Evaluation and Management of Chronic Hepatitis C Virus (HCV) Infection.
Federal Bureau of Prisons Clinical Guidance. 2018.
HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C.
American Association for the Study of Liver Diseases (AASLD)/Infectious Diseases Society of America (IDSA), Last updated November 2019.
Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force (USPSTF) Recommendation Statement.
USPSTF. JAMA. 2020;323(10):970-975.
Clinical Resources
A Guide to Comprehensive Hepatitis C Counseling and Testing.
Centers for Disease Control and Prevention (CDC).
Harm Reduction Coalition.
HEP Drug Interactions.
University of Liverpool (last reviewed May 2019).
PREP-C: Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment.
Mount Sinai School of Medicine.
Rural Health Information Hub.
Action and Advocacy
Center for Health Law and Policy Innovation (CHLPI)
CHLPI advocates for legal, regulatory, and policy reforms to improve the health of underserved populations. It has played a pivotal role in removing Medicaid restrictions on HCV treatment.
Hepatitis Education Project (HEP)
HEP provides support, education, advocacy, and direct services for people affected by hepatitis, and works to raise hepatitis awareness among patients, medical providers, and the general public.
National Hepatitis Corrections Network (NHCN)
NHCN, managed by HEP, supports a public health approach to hepatitis education, prevention, testing, and treatment in prisons and jails.
National Viral Hepatitis Roundtable
National Viral Hepatitis Roundtable (NVHR) is a coalition working together to eliminate hepatitis B and C in the U.S. It offers practical online resources for practice management.
Project ECHO (Extension for Community Healthcare Outcomes)
Project ECHO is a collaborative, telecommunications-based model of medical education and care management designed to train primary care clinicians to provide specialty care in rural and underserved communities.
Substance Abuse and Mental Health Services Administration (SAMHSA): Locator Map
SAMHSA provides an interactive national map that facilitates identification of local resources and services for substance use and mental health disorders.
Patient Resources
Addiction Group
Addiction Group is an informational website that provides authoritative medical content and treatment resources for individuals with substance use disorders, alcohol use disorders, and/or co-occurring mental health disorders.
Hepatitis C Information Center
American Liver Foundation.
The American Liver Foundation’s Hepatitis C Information Center website is a dedicated online information and resource center created in support of individuals impacted by HCV infection.
HepatitisC.net
HepatitisC.net is a website for people living with HCV that offers education, tools, and resources. Articles are written by people living with or cured of HCV, patient advocates, and medical providers.
Hepatitis C Questions and Answers for the Public
Centers for Disease Control and Prevention (CDC; last reviewed November 2018). The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This patient-directed website addresses basics across the HCV clinical continuum.
The BodyPro - Project Inform
Project Inform promotes the development of effective HIV and HCV therapies; supports patients’ informed choices about their health; advocates for quality, affordable health care; and addresses medical strategies that prevent new infections.
Suggested Readings
Knowledge, attitudes, and practices related to hepatitis C among gay and bisexual men in the era of direct-acting antivirals: implications for treatment and prevention.
Brener L, et al. J Cult Health Sex. 2020;22(5):551-567.
Individual and network factors associated with HCV treatment uptake among people who inject drugs.
Falade-Nwulia O, et al. Int J Drug Policy. 2020;78:102714.
“Everybody living with a chronic disease is entitled to be cured”: challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs.
Goodyear T, et al. Int J Drug Policy. 2020;81:102766.
Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: a meta-analysis.
Hajarizadeh B, et al. J Hepatol. 2020;72(4):643-657.
Hepatitis C in pregnancy: a unique opportunity to improve the hepatitis C cascade of care.
Kushner T, Terrault NA. Hepatol Commun. 2019;3(1):20-28.
Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—the practitioner experience.
Marshall AD, et al. Drug Alcohol Depend. 2020;206:107705.
Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.
Masson CL, et al. BMC Infect Dis. 2020;20(1):386.
Interactive PresentationAddressing Barriers and Challenges to HCV Elimination
Narrated by Robert Greenwald
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships
Relevant Resources
The PCPs Role in Preventing HIV
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis
What Do You Know About PrEP?
Got it? Treat it!
The Critical Role of the Community Pharmacist
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
The Emerging Role of the Diabetologist
Key Issues Impacting OB/GYN Practice
An Interactive Experience Highlighting Recent Clinical Advances
Hot Topics in HBV, HCV, and NASH
Emerging Concepts in Patient Management
Building Your Understanding to Combat a Growing Problem
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Why It Matters in OB/GYN Practice Today
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
How the Pharmacist Can Make a Difference
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Understanding the Growing Syndemic — Opioids, HCV, and HIV
Appraising the Therapeutic Armamentarium in Moderate and Severe Disease
A PrEP Primer
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
The Rapid ART Standard of Care: From Evidence to Healthcare Equity
Maximizing Your Role to Impact Patient Outcomes
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Benefits, Barriers, & Best Practices in an Advancing Field
Practical Solutions Across the Spectrum of Care
Informing the Future of NASH Diagnosis and Assessment
A PEP/PrEP Training Guide for Pharmacists
An Interactive Learning Experience
A Focus on Clinical Evidence and Guideline Recommendations
A Critical Step Toward HCV Elimination
Considering the Patient, the Provider, and the Science
A Multidisciplinary Online Mini-Curriculum
Volume 1: A Guided Tour of the Evidence Driving Selection of First-line Advanced Therapies in Moderate to Severe IBD
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies
Establishing Clinical Readiness Through Mentored Learning
Interdisciplinary Strategies for Adult and Pediatric Patients
Interdisciplinary Management of Eosinophilic Esophagitis and Hereditary Angioedema
A Multidisciplinary Look at Early Diagnosis and Management
Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment
Best Practices for Diagnosis and Management
An Update on Best Practices
New Avenues to Pre-Exposure Prophylaxis
An Updated Clinician’s Guide to Assessment and Management
What the Pharmacist Needs to Know
A Look at the Changing HIV Playing Field
A “How To” Series Spanning Policy to Practice
Test Your Mastery!
Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention
Bringing HIV Prevention to a New Level
Optimizing HIV Prevention in Primary Care
Monoclonal Antibodies for the Prevention and Treatment of COVID-19
A Multidisciplinary Approach
Exploring New Treatment Avenues in Nonadvanced Systemic Mastocytosis
A Phone-a-Friend CME Series – Volume 2
Incorporating New Data and Updated Guidelines Into Daily Practice
